Alglucosidase alfa 1.7g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 1.7g/1litre infusion bags

special order - alglucosidase alfa - infusion - 1.7mg/1ml

Alglucosidase alfa 1.8g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 1.8g/1litre infusion bags

special order - alglucosidase alfa - infusion - 1.8mg/1ml

Alglucosidase alfa 1.9g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 1.9g/1litre infusion bags

special order - alglucosidase alfa - infusion - 1.9mg/1ml

Alglucosidase alfa 1.85g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 1.85g/1litre infusion bags

special order - alglucosidase alfa - infusion - 1.85mg/1ml

Alglucosidase alfa 2.2g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 2.2g/1litre infusion bags

special order - alglucosidase alfa - infusion - 2.2mg/1ml

Alglucosidase alfa 2.1g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 2.1g/1litre infusion bags

special order - alglucosidase alfa - infusion - 2.1mg/1ml

Alglucosidase alfa 2g/1litre infusion bags Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alglucosidase alfa 2g/1litre infusion bags

special order - alglucosidase alfa - infusion - 2mg/1ml

Myozyme Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

myozyme

pharmacy retailing (nz) ltd t/a healthcare logistics - alglucosidase alfa 52.5mg;  ;  ;   - powder for infusion concentrate - 50 mg/10ml - active: alglucosidase alfa 52.5mg       excipient: dibasic sodium phosphate heptahydrate mannitol monobasic sodium phosphate monohydrate nitrogen polysorbate 80 - myozyme is indicated for the long - term treatment of patients with a confirmed diagnosis of pompe disease (acid alfa - glucosidase deficiency).

Myozyme Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

myozyme

sanofi b.v. - alglucosidase alfa - glycogen storage disease type ii - other alimentary tract and metabolism products, - myozyme is indicated for long-term enzyme-replacement therapy (ert) in patients with a confirmed diagnosis of pompe disease (acid-α-glucosidase deficiency).in patients with late-onset pompe disease the evidence of efficacy is limited.

NEXVIAZYME POWDER FOR SOLUTION Kanada - Kiingereza - Health Canada

nexviazyme powder for solution

sanofi-aventis canada inc - avalglucosidase alfa - powder for solution - 100mg - avalglucosidase alfa 100mg - enzymes